Spotlight -

Nicholas Jacobus

Articles by Nicholas Jacobus

Agenus Closes $141 Million Immunotherapy Collaboration with Zydus Lifesciences

January 15th 2026

The partnership boosts BOT+BAL immunotherapy, securing US biologics manufacturing and accelerating Phase III mCRC development globally.

Johnson & Johnson Announces Second $2 Billion Manufacturing Facility in North Carolina

ByNicholas Jacobus

January 12th 2026

Johnson & Johnson reinforces its long-term domestic investment strategy with a new $2 billion biologics facility in Wilson, North Carolina, further elevating the state’s role as a global life sciences hub.